Page results
-
ME/CFS is a condition where chronic fatigue is not, much relieved by rest. It affects daily functioning and may also trigger joint pains, mood and sleep disturbance, concentration difficulties, headaches, intestinal and urinary symptoms.
-
This information describes the different types of anaesthetic you might require for your operation.
-
Information about the integrated physiotherapy service at the Royal London Hospital for Integrated Medicine.
-
Learn more about the Spectra Optia Funding to Deliver More Apheresis Capacity for Patients
-
As part of Together Type 1, Diabetes UK are excited to invite young people to join an engaging online ‘Type 1 Chat’.
-
The Macmillan Support and Information Service have developed an online programme of workshops and videos. These give advice to support people who have cancer or a blood condition to manage well from diagnosis onwards.
-
This clinic specialises in the diagnosis and treatment of adult patients with allergic conditions.
-
The Insomnia and Behavioural Sleep Medicine Clinic treats people with insomnia, nightmares, body clock disorders, restless legs, sleep paralysis and related disorders.
-
Information about the musculoskeletal medicine service at the Royal London Hospital for Integrated Medicine.
-
Information about the nutrition and dietetics service at the Royal London Hospital for Integrated Medicine
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment